Grannus Therapeutics
Operator of a pre-clinical stage biotechnology company, aiming to support a cancer treatment. The company develops a molecule that selectively inhibits specific isoforms of Hsp90, addresses the toxici...
Valuation
$0
Share Price
N/A
Total Raised
$2.9M
Last Round
N/A